Introduction Human papilloma virus positive (HPV+) OPSCC has a favorable prognosis compared to its HPV- carcinomas but a significant proportion of patients will experience disease recurrence and death. Enhancement of surveillance strategies after treatment for primary HPV + OPSCC is of great importance.
Iocca et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: